Page last updated: 2024-11-10

azoxystrobin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

azoxystrobin: a methoxyacrylate analog; a strobilurin fungicide; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

azoxystrobin : An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 2-methoxy-1-(methoxycarbonyl)vinyl substituent, also at C-2. An inhibitor of mitochondrial respiration by blocking electron transfer between cytochromes b and c1, it is used widely as a fungicide in agriculture. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3034285
CHEMBL ID230001
CHEBI ID40909
SCHEMBL ID55087
SCHEMBL ID18823
MeSH IDM0232164

Synonyms (86)

Synonym
methyl (e)-2-(2-(6-(2-cyanopheoxy)pyrimidin-4-yloxy)phenyl)-3-methoxypropenoate
bankit
icia-5504
amistar
heritage
quadris
ici-a 5504
hsdb 7017
einecs annex i index 607-256-00-x
benzeneacetic acid, 2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-alpha-(methoxymethylene)-, methyl ester, (e)-
azoxystrobin
NCGC00163818-01
131860-33-8
methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate
NCGC00163818-02
DB07401
dndi1511705
chebi:40909 ,
CHEMBL230001
TCMDC-125883 ,
methyl (e)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-methoxyprop-2-enoate
A806322
(e)-2-[2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]phenyl]-3-methoxy-2-propenoic acid methyl ester
NCGC00163818-04
NCGC00163818-03
NCGC00163818-05
azoxy-strobin
methyl (2e)-2-(2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)phenyl)-3-methoxyacrylate
215934-32-0
C18558
benzeneacetic acid, 2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-alpha-(methoxymethylene)-, methyl ester, (alphae)-
unii-nyh7y08ipm
azoxystrobin [iso]
nyh7y08ipm ,
tox21_400087
dtxcid8012520
cas-131860-33-8
dtxsid0032520 ,
methyl (e)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-methoxy -prop-2-enoate
methyl (e)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate
methyl (2e)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyprop-2-enoate
(alphae)-2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]-alpha-(methoxymethylene) benzeneacetic acid methyl ester
AKOS015900562
azoxystrobin [hsdb]
methyl (.alpha.e)-2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-.alpha.-(methoxymethylene)benzeneacetate
azoxystrobin [mi]
ici-a-5504
(.alpha.e)-2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-.alpha.-(methoxymethylene)benzeneacetic acid methyl ester
SCHEMBL55087
SCHEMBL18823
1SQB
methyl (e)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
(e)-methyl 2-[2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)pheny]-3-methoxypropenoate
methyl (e)-2-{2-[6-(2-cyano-phenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
(e)-methyl 2-[2-(6- (2-cyanophenoxy)pyrimidin-4-yloxy)phenyl]-3-methoxypropenoate
(e)-methyl 2-[2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)phenyl]-3-methoxypropenoate
azoxystrobin, certified reference material, tracecert(r)
azoxystrobine x
KS-5365
methyl (2e)-2-(2-{[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy}phenyl)-3-methoxyacrylate
AC-24498
J-519625
mfcd08277047
azoxystrobin, pestanal(r), analytical standard
bdbm50487147
F20623
azoxystrobin 10 microg/ml in cyclohexane
benzeneacetic acid, 2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]-alpha-(methoxymethylene)-, methyl ester, (alphae)-
J-006072
(e)-methyl 2-(2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)phenyl)-3-methoxyacrylate
bankit; cruiser extreme;ici-a 5504
Q2013860
CS-0012863
AMY3587
HY-B0849
azoxystrobin 1000 microg/ml in acetone
azoxystrobin 1000 microg/ml in toluene
40 - fungicides
(alphae)-2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-alpha-(methoxymethylene) benzeneacetic acid methyl ester
methyl (e)-2-(2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)phenyl)-3-methoxyacrylate
methyl (2e)-2-(2-((6-(2-cyanophenoxy)pyrimidin-4-yl)oxy)phenyl)-3-methoxyprop-2-enoate
usepa/opp pesticide code: 128810
methyl (alphae)-2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-alpha-(methoxymethylene)benzeneacetate
methyl(e)-2-(2-(6-(2-cyanophenoxy)pyrimidin-4-yloxy)phenyl)-3-methoxyacrylate
(alphae)-2-((6-(2-cyanophenoxy)-4-pyrimidinyl)oxy)-alpha-(methoxymethylene)benzeneacetic acid methyl ester
annex i index 607-256-00-x

Research Excerpts

Overview

Azoxystrobin is a broad-spectrum, systemic and soil-applied fungicide used for crop protection against the four major classes of pathogenic fungi. It was recently added to mold- and mildew-resistant wallboards.

ExcerptReferenceRelevance
"Azoxystrobin (AZ) is a broad-spectrum strobilurin fungicide that is used in agriculture and was recently added to mold- and mildew-resistant wallboards. "( Detection of Azoxystrobin Fungicide and Metabolite Azoxystrobin-Acid in Pregnant Women and Children, Estimation of Daily Intake, and Evaluation of Placental and Lactational Transfer in Mice.
Engel, SM; Hsiao, YC; Hu, W; Jiménez, JA; Lin, W; Liu, CW; Lu, K; McCoy, ES; Zylka, MJ, 2022
)
2.53
"Azoxystrobin (AZO) is a broad-spectrum strobilurin fungicide widely used in agriculture. "( An integrated approach for evaluating the interactive effects between azoxystrobin and ochratoxin A: Pathway-based in vivo analyses.
Chen, C; Huang, N; Ji, J; Wang, R, 2023
)
2.59
"Azoxystrobin is a broad-spectrum strobilurin fungicide for use on a wide range of crops available to end-users as formulated products. "( Embryonic zebrafish response to a commercial formulation of azoxystrobin at environmental concentrations.
Félix, LM; Venâncio, CAS; Vieira, RSF, 2021
)
2.31
"Azoxystrobin (AZ) is a broad-spectrum synthetic fungicide widely used in agriculture globally. "( Azoxystrobin amine: A novel azoxystrobin degradation product from Bacillus licheniformis strain TAB7.
Alias, A; Chakraborty, J; Kimura, T; Malon, M; Mpofu, E; Nojiri, H; Ogura, Y; Okada, K; Suzuki-Minakuchi, C; Takikawa, H; Tomita, K, 2021
)
3.51
"Azoxystrobin is a broad-spectrum, systemic and soil-applied fungicide used for crop protection against the four major classes of pathogenic fungi. "( Phytoremediation of azoxystrobin and its degradation products in soil by P. major L. under cold and salinity stress.
Romeh, AAA, 2017
)
2.22
"Azoxystrobin (AZ) is an effective broad-spectrum fungicide. "( Acute toxicity of the fungicide azoxystrobin on the diatom Phaeodactylum tricornutum.
Du, B; Fu, Z; Li, Y; Liu, W; Lu, T; Qian, H; Ye, Y; Zhang, Z; Zhou, Z, 2019
)
2.24
"Azoxystrobin is a systemic fungicide that has a tendency to accumulate at the surface of crop leaves or inside their cuticle where it undergoes photodegradation. "( Phototransformation of azoxystrobin fungicide in organic solvents. Photoisomerization vs. photodegradation.
Chastain, J; de Sainte Claire, P; Richard, C; ter Halle, A; Traikïa, M; Voyard, G, 2013
)
2.14
"Azoxystrobin is a frequently used fungicide in agriculture. "( Genotoxicity and oxidative stress induced by the fungicide azoxystrobin in zebrafish (Danio rerio) livers.
Han, Y; Liu, T; Wang, J; Zhang, C; Zhu, L, 2016
)
2.12
"Azoxystrobin is a broad-spectrum systemic fungicide widely used worldwide to combat pathogenic fungi affecting plants."( Synthesis of azoxystrobin transformation products and selection of monoclonal antibodies for immunoassay development.
Abad-Fuentes, A; Abad-Somovilla, A; Agulló, C; Mercader, JV; Parra, J, 2012
)
1.47
"Azoxystrobin is a modern strobilurin fungicide used around the world to combat prime diseases affecting highly valuable crops. "( Generation of anti-azoxystrobin monoclonal antibodies from regioisomeric haptens functionalized at selected sites and development of indirect competitive immunoassays.
Abad-Fuentes, A; Abad-Somovilla, A; Agulló, C; Mercader, JV; Parra, J, 2012
)
2.15

Effects

Azoxystrobin has been widely used since 1996 to control rice blast caused by Pyricularia oryzae.

ExcerptReferenceRelevance
"Azoxystrobin has been widely used since 1996 to control rice blast caused by Pyricularia oryzae. "( Development of a LAMP method for detecting F129L mutant in azoxystrobin-resistant Pyricularia oryzae.
Deng, Y; Li, C; Qi, Z; Wang, K; Wang, Y; Yang, D; Zhang, H, 2022
)
2.41
"Azoxystrobin (AZ) has entered aquatic ecosystems and produced serious damages to fish associated with potentially increasing the susceptibility to pathogens. "( Azoxystrobin increases the infection of spring viraemia of carp virus in fish.
Chen, J; Liu, L; Qiu, TX; Wang, H; Xu, M, 2021
)
3.51
"azoxystrobin acid) have been detected as contaminants of freshwater systems."( Isolation and characterisation of azoxystrobin degrading bacteria from soil.
Bending, GD; Howell, CC; Semple, KT, 2014
)
1.4
"Azoxystrobin has been widely used in recent years. "( Integrated assessment of oxidative stress and DNA damage in earthworms (Eisenia fetida) exposed to azoxystrobin.
Han, Y; Wang, J; Xie, H; Zhang, S; Zhu, L, 2014
)
2.06
"Azoxystrobin has been registered for rice cultivation in India, but no information is available on its leaching behaviour in Indian soils."( Leaching behaviour of azoxystrobin and metabolites in soil columns.
Ghosh, RK; Singh, N, 2009
)
1.39
"Azoxystrobin has been detected on hands, shoulders and chest."( Assessment of the dermal exposure to azoxystrobin among women tending cucumbers in selected Polish greenhouses after restricted entry intervals expired--the role of the protective gloves.
Hanke, W; Jurewicz, J; Ligocka, D; Sobala, W, 2009
)
1.35

Treatment

Azoxystrobin treatments (125 or 250 g AI ha-1) were applied at various stages of the infection process under controlled conditions. No significant effect on relative Tri5 expression or DON quantity.

ExcerptReferenceRelevance
"Azoxystrobin treatments to ginseng plants at all growth stages suggest that the azoxystrobin-induced delay of senescence is due to an enhanced antioxidant enzyme activity protecting the plants from harmful active oxygen species (AOS)."( Two new fatty acids esters were detected in ginseng stems by the application of azoxystrobin and the increasing of antioxidant enzyme activity and ginsenosides content.
Hou, ZG; Liang, S; Lu, ZB; Wang, XH; Xu, XW; Zhao, XF, 2016
)
1.38
"Azoxystrobin treatment showed no significant effect on either relative Tri5 expression or DON quantity."( Deoxynivalenol biosynthesis-related gene expression during wheat kernel colonization by Fusarium graminearum.
Hallen-Adams, HE; Kuldau, GA; Trail, F; Wenner, N, 2011
)
1.09
"Azoxystrobin treatments (125 or 250 g AI ha-1) were applied at various stages of the infection process under controlled conditions."( Microscopic analysis of the effect of azoxystrobin treatments on Mycosphaerella graminicola infection using green fluorescent protein (GFP)-expressing transformants.
Cavelier, N; Hollomon, DW; Rohel, EA, 2001
)
1.3

Toxicity

The toxic effects of azoxystrobin on zebrafish (Danio rerio) were investigated. The study was carried out on earthworms (Eisenia fetida) in three different natural soils.

ExcerptReferenceRelevance
"In the past few decades, extensive application of azoxystrobin has led to great concern regarding its adverse effects on aquatic organisms."( Reproductive toxicity of azoxystrobin to adult zebrafish (Danio rerio).
Cao, F; Li, H; Qiu, L; Wang, C; Yu, S; Zhu, L, 2016
)
0.99
" In the present work, the toxic effects of azoxystrobin on zebrafish (Danio rerio) were investigated."( Genotoxicity and oxidative stress induced by the fungicide azoxystrobin in zebrafish (Danio rerio) livers.
Han, Y; Liu, T; Wang, J; Zhang, C; Zhu, L, 2016
)
0.94
" Risk assessments revealed that the acceptable daily intake percentage is substantially below the risk level of consumption at day 0 (in both areas), thus encouraging its safe consumption."( Dynamic residual pattern of azoxystrobin in Swiss chard with contribution to safety evaluation.
Abd El-Aty, AM; Chang, BJ; Chung, HS; Farha, W; Jeon, JS; Kabir, MH; Lee, HS; Rahman, MM; Shim, JH; Shin, HC; Wang, J, 2018
)
0.77
" To assess the ecological risk of azoxystrobin in real soil environments, we performed a study on the toxic effects of azoxystrobin on earthworms (Eisenia fetida) in three different natural soils (fluvo-aquic soil, black soil and red clay soil) and an artificial soil."( Ecotoxicity evaluation of azoxystrobin on Eisenia fetida in different soils.
Allen, SC; Du, Z; Hou, K; Li, B; Li, W; Wang, J; Xu, Y; Zhu, L, 2021
)
1.2
" In view of the adverse toxic effects of both on the mammalian liver, it is necessary to conduct a cumulative risk assessment of their dietary exposure to consumers."( Dissipation and Residue of Metalaxyl-M and Azoxystrobin in Scallions and Cumulative Risk Assessment of Dietary Exposure to Hepatotoxicity.
Chai, Y; Du, X; Liu, R; Yuan, L, 2022
)
0.98
" Still, adverse environmental and human health effects resulting from its application have been reported."( Recommended rates of azoxystrobin and tebuconazole seem to be environmentally safe but ineffective against target fungi.
Aguiar, N; Alves, A; Gonçalves, FJM; Pereira, JL; Pereira, P; Queirós, L, 2023
)
1.23

Bioavailability

Little is known about the bioavailability of azoxystrobin in the soil-vegetable system. In the current study we investigated the effect of BC onBioavailability of the fungicide azoxy Strobin.

ExcerptReferenceRelevance
" In the current study we investigated the effect of BC on bioavailability of the fungicide azoxystrobin in soil."( Impacts of biochar on bioavailability of the fungicide azoxystrobin: a comparison of the effect on biodegradation rate and toxicity to the fungal community.
Bending, GD; Sopeña, F, 2013
)
0.86
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"Although azoxystrobin has been widely applied on various crops, little is known about the bioavailability of azoxystrobin in the soil-vegetable system."( Uptake, Accumulation, and translocation of azoxystrobin by Vegetable plants in soils: influence of soil characteristics and plant species.
Fang, H; Shen, F; Song, J; Wang, Y; Xu, S; Yu, Y; Zhang, L, 2022
)
1.4

Dosage Studied

The results demonstrated that the safety of using azoxystrobin at the recommended agriculture dosage to protect bananas from diseases. Their physico-chemical properties suggest difenoconazole and azoxy Strobin should be stable in bananas and soil. Both decreased to safe concentrations by the minimum harvest time after spraying the mixture.

ExcerptRelevanceReference
" Reduction by half of azoxystrobin dosage had little or no effect on azoxystrobin efficiency in controlling M graminicola."( Microscopic analysis of the effect of azoxystrobin treatments on Mycosphaerella graminicola infection using green fluorescent protein (GFP)-expressing transformants.
Cavelier, N; Hollomon, DW; Rohel, EA, 2001
)
0.9
" These results suggest that the choice of the fungicide partner and its dosage in the mixture can significantly affect the success of QoI resistance management strategies under practical conditions."( Effect of dose rate and mixtures of fungicides on selection for QoI resistance in populations of Plasmopara viticola.
Deparis, F; Genet, JL; Jaworska, G, 2006
)
0.33
" From dose-response curve, half maximal inhibitory concentration (IC50) was determined for each strain."( Assessment of Mycosphaerella graminicola resistance to azoxystrobin.
Deweer, C; Halama, P; Morand, E; Reignault, P; Siah, A, 2008
)
0.59
" The results demonstrated that the safety of using azoxystrobin at the recommended agriculture dosage to protect bananas from diseases."( Dissipation and residue of azoxystrobin in banana under field condition.
Liu, Y; Sun, H; Wang, S, 2013
)
0.94
" The pesticides were applied at exaggerated dosage to quantify residue levels in processed samples."( Effect of household and commercial processing on acetamiprid, azoxystrobin and methidathion residues during crude rapeseed oil production.
Jiang, Y; Li, Y; Pan, C; Shibamoto, T, 2013
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
mitochondrial cytochrome-bc1 complex inhibitornull
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
quinone outside inhibitorA mitochondrial cytochrome-bc1 complex inhibitor that acts at the Quinone 'outer' (Qo) binding site of the cytochrome-bc1 complex.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
aryloxypyrimidine
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
enol etherEthers ROR' where R has a double bond adjacent to the oxygen of the ether linkage.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
methoxyacrylate strobilurin antifungal agentAny strobilurin antifungal agent that contains a methoxyacrylate group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (48)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency89.35840.002541.796015,848.9004AID1347398
pregnane X receptorRattus norvegicus (Norway rat)Potency1.99530.025127.9203501.1870AID651751
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency58.60423.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency1.01710.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency42.59330.173734.304761.8120AID1346859; AID1346924
Fumarate hydrataseHomo sapiens (human)Potency14.12540.00308.794948.0869AID1347053
SMAD family member 3Homo sapiens (human)Potency42.59330.173734.304761.8120AID1346859; AID1346924
TDP1 proteinHomo sapiens (human)Potency0.23010.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency0.56690.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency13.33850.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency65.62590.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency10.70300.001022.650876.6163AID1224838; AID1224839
progesterone receptorHomo sapiens (human)Potency52.91110.000417.946075.1148AID1346784; AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency20.00480.01237.983543.2770AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency26.03950.000214.376460.0339AID588533; AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency6.34650.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency39.84270.000817.505159.3239AID1159527; AID1159531; AID588546
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency6.65040.001530.607315,848.9004AID1224819; AID1224820; AID1224821; AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency38.11870.375827.485161.6524AID588526; AID743217; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency2.33350.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.55220.000229.305416,493.5996AID1259244; AID1259248; AID588513; AID588514; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
GVesicular stomatitis virusPotency1.26220.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency31.70550.00108.379861.1304AID1645840
polyproteinZika virusPotency14.12540.00308.794948.0869AID1347053
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency54.72330.001024.504861.6448AID588535; AID743212; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency26.14830.001019.414170.9645AID588536; AID588537; AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency27.42440.023723.228263.5986AID743222; AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency7.69590.000723.06741,258.9301AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency32.67410.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency59.74060.001628.015177.1139AID1224843; AID1259385; AID1259395
activating transcription factor 6Homo sapiens (human)Potency1.09620.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency9.288119.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency65.75490.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency15.96230.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.01260.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.56660.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency6.90090.000627.21521,122.0200AID651741; AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency5.17850.001557.789015,848.9004AID1259244
Interferon betaHomo sapiens (human)Potency14.14540.00339.158239.8107AID1347407; AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency1.26220.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency1.63760.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency5.17850.001551.739315,848.9004AID1259244
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)Potency19.95260.015823.527344.6684AID651778
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency1.26220.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency1.26220.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain C, Cytochrome bBos taurus (cattle)IC50 (µMol)0.01120.01120.01120.0112AID977608
Chain C, Cytochrome bBos taurus (cattle)IC50 (µMol)0.01120.01120.01120.0112AID977608
Cytochrome bSus scrofa (pig)Ki0.29760.00330.15350.2976AID1091872
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (214)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (63)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (36)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (179)

Assay IDTitleYearJournalArticle
AID1112830Fungicidal activity against Magnaporthe oryzae assessed as germination of conidia at 1 mg/l at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID297517Antimicrobial activity against Fusarium solani at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1367218Antifungal activity against Botrytis cinerea assessed as inhibition of mycelium growth at 5 ug/ml after 48 hrs relative to control2017Bioorganic & medicinal chemistry, 12-15, Volume: 25, Issue:24
Synthesis, antifungal and antitumor activity of two new types of imidazolin-2-ones.
AID1090505Antifungal activity against Colletotrichum acutatum assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID1112835Fungicidal activity against Magnaporthe oryzae assessed as inhibition of sporulation at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1091304Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1091295Fungicidal activity against Blumeria graminis infected wheat plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 1.56 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1091299Fungicidal activity against Podosphaera fuliginea infected compound pre-treated cucumber plants assessed as disease preventive activity at 0.78 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1080482Antifungal activity against Colletotrichum gloeosporioides assessed as as appearance of diffuse zone of inhibition at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID297518Antimicrobial activity against Fusarium solani at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1111110Antifungal activity against Pseudoperonospora cubensis infected cucumber leaves assessed as disease control at 400 mg/l after 5 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID297519Antimicrobial activity against Fusarium oxysporum at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1111109Antifungal activity against Pseudoperonospora cubensis infected cucumber leaves assessed as disease control at 25 mg/l after 5 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID611600Competitive inhibition of pig heart Cytochrome b-c1 complex using DBH2 as substrate in absence of lauryl maltoside by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID1105339Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelium growth at 50 ug/ml relative to control2011Molecules (Basel, Switzerland), Oct-25, Volume: 16, Issue:11
Design, synthesis and antifungal/insecticidal evaluation of novel cinnamide derivatives.
AID1081082Inhibition of intact mycelial respiration of Phytophthora capsici assessed as superpose rate of oxygen consumption at 10 ug/mL in presence of malonic acid2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1091307Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 3.12 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081292Fungicidal activity against Rhizoctonia solani assessed as inhibition of intact mycelia respiration at 10 ug/mL by cell membrane permeability assay2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Primary study on mode of action for macrocyclic fungicide candidates (7B3, D1) against Rhizoctonia solani Kuhn.
AID611602Competitive inhibition of pig heart Cytochrome b-c1 complex using DBH2 as substrate by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID1081086Inhibition of intact mycelial respiration of Phytophthora capsici at 10 ug/mL in presence of sodium phosphate2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1091301Fungicidal activity against Podosphaera fuliginea infected compound pre-treated cucumber plants assessed as disease preventive activity at 1.56 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID346925Inhibition of Phytophthora infestans cytochrome bc1 complex inoculated in tomato plant assessed as lowest drug concentration required to control 100% disease applied to leaf 1 hr prior inoculation measured after 6 to 9 days2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID297521Antimicrobial activity against Fusarium solani at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID297520Antimicrobial activity against Fusarium oxysporum at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID376577Antifungal activity against Colletotrichum fragariae assessed as zone of inhibition2000Journal of natural products, Aug, Volume: 63, Issue:8
A new 2D-TLC bioautography method for the discovery of novel antifungal agents To control plant pathogens.
AID1111614Fungicidal activity against Pseudoperonospora cubensis at 6.25 mg/L relative to untreated control2011Pest management science, Jun, Volume: 67, Issue:6
Design, synthesis and structure-activity relationship of novel coumarin derivatives.
AID1081081Inhibition of intact mycelial respiration of Phytophthora capsici assessed as superpose rate of oxygen consumption at 10 ug/mL in presence of iodoacetic acid2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1091300Fungicidal activity against Podosphaera fuliginea infected compound pre-treated cucumber plants assessed as disease preventive activity at measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081041Antifungal activity against Magnaporthe oryzae assessed as inhibition at 25 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID611599Non-competitive inhibition of pig heart succinate-cytochrome c reductase (Electron transport protein complex 2/3) using cytochrome c as substrate by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID1111105Antifungal activity against Blumeria graminis f. sp. tritici infected seven-day-old wheat seedlings assessed as disease control at 12.5 mg/l after 7 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID1882204Antifungal activity against sunflower Sclerotinia rot at 50 ug/ml relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Natural and synthetic β-carboline as a privileged antifungal scaffolds.
AID1081088Inhibition of intact mycelial respiration of Phytophthora capsici at 10 ug/mL in presence of malonic acid2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1112836Fungicidal activity against Magnaporthe oryzae assessed as inhibition of mycelium growth at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1112831Fungicidal activity against Magnaporthe oryzae assessed as germination of conidia at 0.01 mg/l at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1111112Antifungal activity against Magnaporthe oryzae infected 12 day old rice plant assessed as disease control at 400 mg/l after 6 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID1111108Antifungal activity against Pseudoperonospora cubensis infected cucumber leaves assessed as disease control at 6.25 mg/l after 5 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID297544Antimicrobial activity against Fusarium proliferatum at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090802Antifungal activity against Colletotrichum acutatum assessed as diffuse inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1091302Fungicidal activity against Podosphaera fuliginea infected compound pre-treated cucumber plants assessed as disease preventive activity at 3.12 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081036Antifungal activity against Pseudoperonospora cubensis assessed as inhibition at 25 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID1103205Antifungal activity against Fusarium graminearum isolate CE135 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1112537Antifungal activity against Botryotinia fuckeliana SAS56 assessed as inhibition of colony growth2012Pest management science, Sep, Volume: 68, Issue:9
Genetic analysis and molecular characterisation of laboratory and field mutants of Botryotinia fuckeliana (Botrytis cinerea) resistant to QoI fungicides.
AID1091290Fungicidal activity against Podosphaera fuliginea infected cucumber plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 0.78 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID346926Inhibition of Plasmopara viticola cytochrome bc1 complex inoculated in vine plant assessed as lowest drug concentration required to control 100% disease applied to leaf 1 hr prior inoculation measured after 6 to 9 days2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID1882203Antifungal activity against rape Sclerotinia rot at 50 ug/ml relative to control2022European journal of medicinal chemistry, Feb-05, Volume: 229Natural and synthetic β-carboline as a privileged antifungal scaffolds.
AID1081033Antifungal activity against Blumeria graminis assessed as inhibition at 6.25 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID1091289Fungicidal activity against Podosphaera fuliginea infected cucumber plants exposed to compound treatment 1 day post infection assessed as disease curative activity measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1111111Antifungal activity against Botryotinia fuckeliana infected cucumber leaves assessed as disease control at 400 mg/l after 4 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID1112834Fungicidal activity against Magnaporthe oryzae assessed as inhibition of sporulation at 1 mg/l at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1111613Fungicidal activity against Pseudoperonospora cubensis at 25 mg/L relative to untreated control2011Pest management science, Jun, Volume: 67, Issue:6
Design, synthesis and structure-activity relationship of novel coumarin derivatives.
AID611606Activity of pig heart succinate-cytochrome c reductase (Electron transport protein complex 2/3) using cytochrome c as substrate by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID1399728Antifungal activity against Phytophthora infestans assessed as inhibition of zoospore release after 4 hrs2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID299150Growth inhibition of Verticillium lamellicola at 50 ug/mL2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
Design and synthesis of beta-methoxyacrylate analogues via click chemistry and biological evaluations.
AID1091294Fungicidal activity against Blumeria graminis infected wheat plants exposed to compound treatment 1 day post infection assessed as disease curative activity measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1090506Antifungal activity against Colletotrichum fragariae assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID297547Antimicrobial activity against Fusarium proliferatum at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091312Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 500 ppm measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081089Inhibition of intact mycelial respiration of Phytophthora capsici at 10 ug/mL2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1103208Antifungal activity against Colletotrichum truncatum CE175 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1091303Fungicidal activity against Podosphaera fuliginea infected compound pre-treated cucumber plants assessed as disease preventive activity at 6.25 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1090800Antifungal activity against Colletotrichum fragariae assessed as size of growth inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1112534Antifungal activity against Botryotinia fuckeliana SAS56 assessed as complete inhibition of colony growth at 3 mg/ml2012Pest management science, Sep, Volume: 68, Issue:9
Genetic analysis and molecular characterisation of laboratory and field mutants of Botryotinia fuckeliana (Botrytis cinerea) resistant to QoI fungicides.
AID297515Antimicrobial activity against Fusarium oxysporum at 0.3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1103201Antifungal activity against Fusarium equiseti (CE181) after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1091291Fungicidal activity against Podosphaera fuliginea infected cucumber plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 1.56 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081087Inhibition of intact mycelial respiration of Phytophthora capsici at 10 ug/mL in presence of iodoacetic acid2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID1081080Inhibition of intact mycelial respiration of Phytophthora capsici assessed as superpose rate of oxygen consumption at 10 ug/mL in presence of sodium phosphate2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Study of inhibitory effects and action mechanism of the novel fungicide pyrimorph against Phytophthora capsici.
AID297526Antimicrobial activity against Fusarium solani at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1666591Inhibition of porcine succinate-ubiquinone oxidoreductase at 10 uM using succinate and 2,6-dichloroindophenol as substrates by spectrophotometric based assay relative to control2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification.
AID1105341Antifungal activity against Phytophthora parasitica assessed as inhibition of mycelium growth at 50 ug/ml relative to control2011Molecules (Basel, Switzerland), Oct-25, Volume: 16, Issue:11
Design, synthesis and antifungal/insecticidal evaluation of novel cinnamide derivatives.
AID1666589Inhibition of porcine succinate-cytochrome c reductase using succinate and cytochrome c as substrates by spectrophotometric based assay2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification.
AID1112536Antifungal activity against Botryotinia fuckeliana SAS405 assessed as inhibition of colony growth2012Pest management science, Sep, Volume: 68, Issue:9
Genetic analysis and molecular characterisation of laboratory and field mutants of Botryotinia fuckeliana (Botrytis cinerea) resistant to QoI fungicides.
AID1091305Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 0.78 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1091293Fungicidal activity against Podosphaera fuliginea infected cucumber plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 6.25 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1105340Antifungal activity against Botryotinia fuckeliana assessed as inhibition of mycelium growth at 50 ug/ml relative to control2011Molecules (Basel, Switzerland), Oct-25, Volume: 16, Issue:11
Design, synthesis and antifungal/insecticidal evaluation of novel cinnamide derivatives.
AID1103203Antifungal activity against Fusarium graminearum isolate CE169 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1090797Antifungal activity against Colletotrichum gloeosporioides assessed as diffuse inhibitory zone at concentration of 2 mM in volume of 2 ul of EtOH measured after 4 days by TLC based direct bioautography assay2007Journal of agricultural and food chemistry, Oct-17, Volume: 55, Issue:21
Chemical composition and antifungal activity of Arnica longifolia, Aster hesperius, and Chrysothamnus nauseosus essential oils.
AID1103204Antifungal activity against Fusarium graminearum isolate CE171 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID297525Antimicrobial activity against Fusarium solani at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1112828Fungicidal activity against Magnaporthe oryzae in five leaf stage carnaroli plants assessed as decrease in disease incidence at 0.01 to 1 mg/l2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1103206Antifungal activity against Fusarium graminearum isolate CE170 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1091313Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 100 ppm measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081034Antifungal activity against Pseudoperonospora cubensis assessed as inhibition at 6.25 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID1399727Antifungal activity against Phytophthora infestans assessed as inhibition of zoospore release at 100 ug/ml after 4 hrs relative to control2018Bioorganic & medicinal chemistry, 09-01, Volume: 26, Issue:16
Synthesis and bioactivities evaluation of l-pyroglutamic acid analogues from natural product lead.
AID1091298Fungicidal activity against Blumeria graminis infected wheat plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 6.25 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID297550Fungistatic activity against Fusarium proliferatum at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1090504Antifungal activity against Colletotrichum gloeosporioides assessed as growth inhibition at 2 uL in 2 mM acetone by direct bioautography2006Journal of agricultural and food chemistry, Sep-06, Volume: 54, Issue:18
Chemical composition and antifungal activity of Salvia macrochlamys and Salvia recognita essential oils.
AID1103202Antifungal activity against Diaporthe longicolla CE117 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID346928Inhibition of cytochrome bc1 complex in bovine heart mitochondria by NADH oxidase assay2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID1367217Antifungal activity against Botrytis cinerea assessed as inhibition of spore germination at 5 ug/ml after 6 hrs by microscopic analysis relative to control2017Bioorganic & medicinal chemistry, 12-15, Volume: 25, Issue:24
Synthesis, antifungal and antitumor activity of two new types of imidazolin-2-ones.
AID1091306Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 1.56 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1111107Antifungal activity against Pseudoperonospora cubensis infected cucumber leaves assessed as disease control at 3.12 mg/l after 5 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID1105344Antifungal activity against Valsa mali assessed as inhibition of mycelium growth at 50 ug/ml relative to control2011Molecules (Basel, Switzerland), Oct-25, Volume: 16, Issue:11
Design, synthesis and antifungal/insecticidal evaluation of novel cinnamide derivatives.
AID346927Inhibition of Puccinia triticina cytochrome bc1 complex inoculated in wheat plant assessed as lowest drug concentration required to control 100% disease applied to leaf 1 hr prior inoculation measured after 6 to 9 days2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID1091310Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 3.1 ppm measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID297555Fungistatic activity against Fusarium oxysporum at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1111106Antifungal activity against Blumeria graminis f. sp. tritici infected seven-day-old wheat seedlings assessed as disease control at 400 mg/l after 7 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID297522Antimicrobial activity against Fusarium solani at 3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1081035Antifungal activity against Blumeria graminis assessed as inhibition at 400 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID297524Antimicrobial activity against Fusarium oxysporum at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1666587Inhibition of porcine cytochrome b-c1 complex using DBH2 and cytochrome c as substrates by spectrophotometric based assay2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
N-(3,5-Dichloro-4-(2,4,6-trichlorophenoxy)phenyl)benzenesulfonamide: A new dual-target inhibitor of mitochondrial complex II and complex III via structural simplification.
AID1091309Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 1.5 ppm measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1091296Fungicidal activity against Blumeria graminis infected wheat plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 0.78 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1080483Antifungal activity against Colletotrichum acutatum assessed as appearance of diffuse zone of inhibition at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1112826Fungicidal activity against Magnaporthe oryzae from perennial ryegrass2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1111104Antifungal activity against Blumeria graminis f. sp. tritici infected seven-day-old wheat seedlings assessed as disease control at 1.56 mg/l after 7 days relative to control2010Pest management science, Jan, Volume: 66, Issue:1
Design, synthesis and biological activities of new strobilurin derivatives containing substituted pyrazoles.
AID1091872Inhibition of Sus scrofa (pig) heart cytochrome bc1 complex using DBH2 as substrate by spectrophotometric analysis2010Journal of the American Chemical Society, Jan-13, Volume: 132, Issue:1
Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues.
AID1081032Antifungal activity against Blumeria graminis assessed as inhibition at 1.56 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID297548Antimicrobial activity against Fusarium proliferatum at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID611601Competitive inhibition of pig heart Cytochrome b-c1 complex using DBH2 as substrate in presence of lauryl maltoside by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID1105343Antifungal activity against Rhizoctonia solani assessed as inhibition of mycelium growth at 50 ug/ml relative to control2011Molecules (Basel, Switzerland), Oct-25, Volume: 16, Issue:11
Design, synthesis and antifungal/insecticidal evaluation of novel cinnamide derivatives.
AID611607Activity of pig heart Cytochrome b-c1 complex using DBH2 as substrate by Line-weaverBurk plot analysis2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, syntheses, and kinetic evaluation of 3-(phenylamino)oxazolidine-2,4-diones as potent cytochrome bc₁ complex inhibitors.
AID297545Antimicrobial activity against Fusarium proliferatum at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1111612Fungicidal activity against Cytospora mandshurica Miura under green house condition in presence of 98% compound2011Pest management science, Jun, Volume: 67, Issue:6
Design, synthesis and structure-activity relationship of novel coumarin derivatives.
AID346924Inhibition of Mycosphaerella graminicola cytochrome bc1 complex inoculated in wheat plant assessed as lowest drug concentration required to control 100% disease applied to leaf 1 hr prior inoculation measured after 6 to 9 days2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID1111607Fungicidal activity against Cytospora mandshurica Miura at 1000 mg/L of 25% compound under field trials condition relative to untreated control2011Pest management science, Jun, Volume: 67, Issue:6
Design, synthesis and structure-activity relationship of novel coumarin derivatives.
AID297523Antimicrobial activity against Fusarium oxysporum at 30 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1720719Inhibition of porcine heart Succinate-cytochrome c reductase complex 2 by measuring decrease in DCIP at 10 uM relative to control2020Bioorganic & medicinal chemistry letters, 08-15, Volume: 30, Issue:16
Design and synthesis of potent inhibitors of bc
AID1112829Fungicidal activity against Magnaporthe oryzae assessed as reduction of appressorium diameter of conidia at 0.01 to 1 mg/l at 26 degC measured after 7 days2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1091308Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 6.25 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1081038Antifungal activity against Pseudoperonospora cubensis assessed as inhibition at 400 mg/L relative to control2010Journal of agricultural and food chemistry, Mar-10, Volume: 58, Issue:5
Synthesis and biological activity of new (E)-alpha-(Methoxyimino)benzeneacetate derivatives containing a substituted pyrazole ring.
AID297546Antimicrobial activity against Fusarium proliferatum at 3 uM after 48 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1091297Fungicidal activity against Blumeria graminis infected wheat plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 3.12 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID299156Effect on growth of Raphanus sativus assessed as length of hypocotyl at 50 ug/mL by seed germination assay2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
Design and synthesis of beta-methoxyacrylate analogues via click chemistry and biological evaluations.
AID297516Antimicrobial activity against Fusarium oxysporum at 0.3 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID346923Inhibition of Blumeria graminis f. sp. Tritici cytochrome bc1 complex inoculated in wheat plant assessed as lowest drug concentration required to control 100% disease applied to leaf 1 hr prior inoculation measured after 6 to 9 days2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.
AID1112825Fungicidal activity against Magnaporthe grisea2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1103207Antifungal activity against Macrophomina phaseolina isolate CE173 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID297549Antimicrobial activity against Fusarium proliferatum at 30 uM after 72 hrs by microtiter assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1112827Fungicidal activity against Magnaporthe oryzae in five leaf stage carnaroli plants assessed as decrease in frequency of type 3 lesions at 0.01 to 1 mg/l2013Pest management science, Feb, Volume: 69, Issue:2
Impact of tricyclazole and azoxystrobin on growth, sporulation and secondary infection of the rice blast fungus, Magnaporthe oryzae.
AID1103209Antifungal activity against Alternaria alternata (CE172) after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1091292Fungicidal activity against Podosphaera fuliginea infected cucumber plants exposed to compound treatment 1 day post infection assessed as disease curative activity at 3.12 mg/L measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1091311Fungicidal activity against Blumeria graminis infected compound pre-treated wheat plants assessed as disease preventive activity at 6.2 ppm measured after 1 or 2 weeks2008Journal of agricultural and food chemistry, Aug-13, Volume: 56, Issue:15
Synthesis and fungicidal activities of novel bis(trifluoromethyl)phenyl-based strobilurins.
AID1080485Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth at 2 mM in 2 uL solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID297552Fungistatic activity against Fusarium solani at 30 uM after 72 hrs by microtiter plate assay2007Journal of medicinal chemistry, Sep-06, Volume: 50, Issue:18
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347084qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Confirmatory Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347081qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Confirmatory Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347087qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Confirmatory Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347088qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): Viability assay - Alamar blue signal for LCMV Confirmatory Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1159585Biochemical screen of P. falciparum CDPK12016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159586Biochemical screen of P. falciparum PK62016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159589Biochemical screen of P. falciparum MAPK22016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159588Biochemical screen of P. falciparum CDPK42016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159587Biochemical screen of P. falciparum PK72016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2004Journal of molecular biology, Jul-30, Volume: 341, Issue:1
Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (340)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (0.29)18.2507
2000's68 (20.00)29.6817
2010's171 (50.29)24.3611
2020's100 (29.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.05 (24.57)
Research Supply Index5.84 (2.92)
Research Growth Index6.05 (4.65)
Search Engine Demand Index145.79 (26.88)
Search Engine Supply Index3.91 (0.95)

This Compound (48.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (1.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other336 (98.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]